Nanobiotix (NBTX) Scheduled to Post Earnings on Tuesday

Nanobiotix (NASDAQ:NBTX – Get Free Report) will be posting its quarterly earnings results after the market closes on Tuesday, September 26th. Persons that wish to listen to the company’s earnings conference call can do so using this link.

Nanobiotix Stock Performance

Nanobiotix stock opened at $8.47 on Friday. Nanobiotix has a 52 week low of $1.75 and a 52 week high of $11.00. The business has a 50-day simple moving average of $8.77 and a 200 day simple moving average of $5.93.

Get Nanobiotix alerts:

Nanobiotix Company Profile

(Get Free Report)

Nanobiotix SA, a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer.

Read More

• Five stocks we like better than Nanobiotix
• What is the NASDAQ Stock Exchange?
• 3 Reasons This Sleeping Giant Is About To Wake Up
• How to Invest in Casino Stocks
• MarketBeat Week in Review – 9/18 – 9/22
• What Is WallStreetBets and What Stocks Are They Targeting?
• 52-week Low Names To Tip The Upside Scale In Your Favor

Receive News & Ratings for Nanobiotix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanobiotix and related companies with MarketBeat.com's FREE daily email newsletter.